A Patient’s Perspective and ongoing Challenges with Patient Access — Panel Discussion: Avicanna's 4th Medical Symposium, Access to Medical Cannabis, Session 2C

Avicanna’s 4th Medical Symposium – On Demand Session 2C: A Patient’s Perspective and Ongoing Challenges with Access This panel brings together expert clinicians and patient advocates to explore the real-world barriers to accessing medical cannabis in Canada. Moderated by Dr. Karolina Urban, the discussion features Dr. Carlo De Angelis, Dr. Blake Pearson, and patient advocate Cristina Montoya. Together, they address the lived experience of patients, the evolving role of healthcare providers, and systemic gaps that hinder effective cannabinoid-based care. Insightful, moving, and solution-oriented, this session is essential viewing for anyone invested in improving equitable access. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

Cannabinoid-Based Medicines in Women’s Health — with Dr. Tania Di Renna: Avicanna's 4th Medical Symposium, Concluding Session, Session 4A

Avicanna’s 4th Medical Symposium – On Demand Session 4A: Cannabinoid-Based Medicines in Women’s Health Dr. Tania Di Renna explores the urgent need for better management of chronic pelvic pain (CPP) in women and the potential role of cannabinoid-based medicines in addressing this unmet need. This session examines the complex, multifactorial nature of CPP, gender disparities in pain care, and the limited access to effective treatments. Dr. Di Renna outlines the emerging evidence and therapeutic promise of cannabis in women's health—particularly in pain management and quality of life. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

Clinical Application of Cannabinoids for Chronic Pain — with Dr. Hance Clarke: Avicanna's 4th Medical Symposium, Clinical Application, Session 3B

Avicanna’s 4th Medical Symposium – On Demand Session 3B: Clinical Application of Cannabinoids for Chronic Pain - with Dr. Hance Clarke Dr. Hance Clarke explores the evolving landscape of cannabis use post-legalization, providing insights from the Federal Task Force review of the Cannabis Act. This session also highlights the clinical application of cannabinoids for chronic pain, with a focus on musculoskeletal conditions and emerging basic science research. Drawing from his leadership in pain medicine, Dr. Clarke offers practical, evidence-informed guidance on integrating cannabis-based therapies into patient care. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

Clinical Practice Guidelines for Chronic Pain and Co-occurring Conditions — with Dr. Alan Bell: Avicanna's 4th Medical Symposium, Clinical Application, Session 3A

Avicanna’s 4th Medical Symposium – On Demand Session 3A: Clinical Practice Guidelines for Chronic Pain and Co-occurring Conditions Dr. Alan Bell presents a comprehensive overview of the 2023 International Clinical Practice Guidelines for cannabis and cannabinoid-based medicines in managing chronic pain and co-occurring conditions. Drawing from a systematic review of current evidence, this session offers practical recommendations using the GRADE framework and includes clinical insights to support real-world application. With over 20 years of cannabinoid experience and a leading voice in Canadian guidelines, Dr. Bell delivers a must-watch for HCPs integrating cannabis into care. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

Evaluating a Cannabidiol Cream in Children with Epidermolysis Bullosa — with Dr. Camila Sofia Arriagada Egnen: Avicanna's 4th Medical Symposium, Real-World Evidence Studies, Session 1B

Avicanna’s 4th Medical Symposium – On Demand Session 1: Exploring Cannabinoid-Based Treatments for Epidermolysis Bullosa This session presents a retrospective cohort study from The Hospital for Sick Children on the use of Ultra-Phyto 3% CBD cream in patients with Epidermolysis Bullosa (EB)—a rare group of congenital blistering skin disorders. With limited treatment options beyond supportive care, this research explores the tolerability and potential therapeutic role of topical cannabidiol (CBD) in managing symptoms such as pain and inflammation. What you’ll learn: ✔️ Overview of EB and current treatment gaps ✔️ Study findings on CBD cream use in pediatric EB patients ✔️ Implications for cannabinoid-based dermatological care 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

Introduction to MyMedi.ca’s Medical Cannabis Care Platform — with Samantha Aitken: Avicanna's 4th Medical Symposium, Access to Medical Cannabis, Session 2A

Avicanna’s 4th Medical Symposium – On Demand Session 2A: Introduction to MyMedi.ca’s Medical Cannabis Care Platform Despite two decades of legal access, medical cannabis in Canada remains difficult to navigate. This session introduces the MyMedi.ca platform and its mission to streamline the patient and prescriber journey through pharmacist-led support, insurance navigation, education, and an evidence-driven formulary. Samantha Aitken walks healthcare professionals through how MyMedi.ca addresses regulatory and systemic barriers—making it easier to refer patients and provide evidence-based cannabinoid care. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

MyMedi.ca Educational Webinar Series - MyMedi.ca Educational Webinar Series Presents: Cannabis, Endocannabinoids and PTSD, with Dr. Matthew Hill

Watch the second event in the MyMedi.ca Educational Webinar Series – now on demand! Join world-renowned neuroscientist Dr. Matthew Hill as he explores the role of cannabis and endocannabinoids in PTSD in this recorded webinar, originally aired on Wednesday, May 28. Topic: Cannabis, Endocannabinoids and PTSD Learning Objectives: ✔️ Review current research on cannabis use in PTSD ✔️ Understand how endocannabinoids regulate stress and fear ✔️ Explore potential benefits of targeting endocannabinoid systems in PTSD treatment Ideal for clinicians, researchers, and anyone interested in cannabinoid-based approaches to mental health care. Sponsored by Cogent and Avicanna

• Course
• By Avicanna Inc

MyMedi.ca Educational Webinar Series - Rethinking Pain, Sleep, and Mental Health: The Role of Cannabinoid-Based Medicines in Today’s Medical Landscape, with Dr. Blake Pearson

MyMedi.ca Educational Webinar Series: Dr. Blake Pearson Rethinking Pain, Sleep & Mental Health: The Role of Cannabinoid-Based Medicines Join Dr. Pearson as he explores the evolving role of cannabinoids in modern care. Key topics include: ✔️ Medical vs. Recreational Use – Why referring to HCPs matters for patient safety ✔️ Opioid Alternatives – What new clinical guidelines now recommend ✔️ Sleep & Cannabinoids – How improved sleep supports pain and mood outcomes ✔️ Practical Tools – How to safely prescribe or refer for cannabinoid-based therapies Perfect for HCPs seeking evidence-based, compliant guidance.

• Course
• By Avicanna Inc

Patient and HCP Resources

• Course
• By Avicanna Inc

Pharmacist Led Cannabis Consultation Service for Sunnybrook Odette Cancer Patient’s: A Case Study in Meeting Patients Needs — with Dr. Carlo De Angelis: Avicanna's 4th Medical Symposium, Access to Medical Cannabis, Session 2B

Avicanna’s 4th Medical Symposium – On Demand Session 2B: Pharmacist-Led Cannabis Consultation Service at Sunnybrook Odette Cancer Centre - With Dr. Carlo De Angelis Dr. Carlo De Angelis shares insights from Canada’s first pharmacist-led Cannabis Consultation Service dedicated to cancer patients. This case study outlines the development and impact of the Sunnybrook Odette program, designed to support oncology patients exploring cannabinoid-based symptom management. With a focus on education, research, and real-world care, Dr. De Angelis highlights the pharmacist’s evolving role in personalized cannabinoid therapy within oncology. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

Results of a Prospective Real-world Evidence Study in Patient’s with Localized Musculoskeletal Pain and Inflammation — with Dr. Karolina Urban: Avicanna's 4th Medical Symposium, Real-World Evidence Studies, Session 1C

Avicanna’s 4th Medical Symposium – On Demand Session 1: Real-World Evidence on Cannabinoids for Musculoskeletal Pain with Dr. Karolina Urban With 24% of Canadians using medical cannabis for arthritis or joint pain, the need for targeted cannabinoid delivery is growing. In this session, Dr. Karolina Urban presents real-world data on cannabinoid-based formulations for localized musculoskeletal pain and inflammation. She explores the path from drug concept to commercialization, including the use of AI in formulation design and prospective evidence generation to refine clinical protocols. What you’ll learn: ✔️ Insights into cannabinoid drug development ✔️ Real-world evidence from patients with musculoskeletal pain ✔️ Applications of AI and advanced delivery systems 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

The Challenges with Establishing Medical Cannabis Treatment Plans for Patients — Panel Discussion: Avicanna's 4th Medical Symposium, Clinical Application, Session 3D

Avicanna’s 4th Medical Symposium – On Demand Session 3D: Panel – Challenges in Medical Cannabis Treatment Planning A multidisciplinary panel explores the complexities of developing cannabinoid-based treatment plans for patients across clinical settings. Moderated by Dr. Karolina Urban (Avicanna), the discussion features Dr. Hance Clarke (chronic pain), Dr. Alan Bell (primary care and guidelines), and Dr. Evan Cole Lewis (pediatric neurology), who share insights into real-world barriers, decision-making, and evolving clinical evidence in the use of medical cannabis. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

The Evolution of Medical Cannabis and Canada’s Leadership — with Aras Azadian: Avicanna's 4th Medical Symposium, Opening Remarks, Session 1A

Avicanna’s 4th Medical Symposium – On Demand Session 1: The Evolution of Medical Cannabis and Canada’s Leadership — with Aras Azadian Canada became the first G7 nation to legalize medical cannabis, setting a global precedent for its integration into healthcare. In this opening session, Aras Azadian explores how the Canadian medical and academic communities have driven advancements in cannabinoid-based medicine — from product innovation and patient support programs to medical training, evidence generation, and insurance inclusion. What you’ll learn: ✔️ Canada’s leadership in global medical cannabis policy ✔️ How the patient journey has evolved over the past decade ✔️ The role of research, insurance, and industry in enabling access 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

The Role and Benefits of Real-world Evidence Studies in Understanding the Potential Therapeutic Benefits of Cannabinoids — Panel Discussion: Avicanna's 4th Medical Symposium, Real-World Evidence Studies, Session 1D

Avicanna’s 4th Medical Symposium – On Demand Session 1: The Role and Benefits of Real-World Evidence in Cannabinoid-Based Medicine This expert panel explores how real-world evidence (RWE) can shape our understanding of the therapeutic potential of cannabinoids. Moderated by Dr. Karolina Urban (Avicanna), the discussion features Dr. Hance Clarke (University Health Network, Canadian Pain Society) and Erin Prosk (Santé Cannabis), who share insights from research, clinical experience, and patient care. Together, they examine how RWE supports the safe, effective integration of medical cannabis into Canadian healthcare. What you’ll learn: ✔️ Why RWE is essential in cannabinoid medicine ✔️ Challenges and opportunities in clinical data collection ✔️ Perspectives from pain management and clinical practice 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

The Role of Industry in Advancing Cannabis-based Medicine — Panel Discussion: Avicanna's 4th Medical Symposium, Concluding Session, Session 4A

Avicanna’s 4th Medical Symposium – On Demand Session 4B, Panel Discussion: The Role of Industry in Advancing Cannabis-Based Medicine This panel explores how industry leaders are shaping the future of medical cannabis. Moderated by Avicanna CEO Aras Azadian, the discussion brings together executives from Canopy Growth and MediPharm Labs to examine industry-driven innovation, commercialization, and global expansion of cannabinoid-based medicines. Hear firsthand how collaboration, compliance, and data-backed development are helping to advance patient access and therapeutic potential in this emerging field. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc

Use of Cannabinoids in Pediatric Refractory Epilepsy Patients — with Dr. Evan Lewis: Avicanna's 4th Medical Symposium, Clinical Application, Session 3C

Avicanna’s 4th Medical Symposium – On Demand Session 3C: Use of Cannabinoids in Pediatric Refractory Epilepsy Dr. Evan Cole Lewis explores the role of cannabinoids in managing pediatric drug-resistant epilepsy. With current anti-seizure medications often falling short, this session examines emerging clinical evidence and real-world outcomes from a Canadian neurology clinic. Dr. Lewis reflects on the potential of cannabis to achieve seizure freedom and the broader implications for clinical practice, research, and policy. 🎓 Powered by Avicenna Academy | Presented by Avicanna

• Course
• By Avicanna Inc